Two TLRs that have received interest in this context are TLR2 and TLR4 (158, 159) with INI-2004 a TLR4 agonist currently undergoing clinical development in allergic rhinitis (NCT06038279). This evidence concerns the gene TLR4 and allergic rhinitis.